Status: current, Defined. Date: 31-Oct 2013. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3750011000168113 | Sevikar HCT 40/5/25 (amlodipine 5 mg + hydrochlorothiazide 25 mg + olmesartan medoxomil 40 mg) tablet, 10 tablets, blister pack (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3750501000168115 | Sevikar HCT 40/5/25 tablet, 10, blister pack | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Sevikar HCT 40/5/25 tablet, 10, blister pack | has TP | Sevikar HCT 40/5/25 | true | Inferred relationship | Some | ||
| Sevikar HCT 40/5/25 tablet, 10, blister pack | has TPUU | Sevikar HCT 40/5/25 tablet | true | Inferred relationship | Some | 1 | |
| Sevikar HCT 40/5/25 tablet, 10, blister pack | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Sevikar HCT 40/5/25 tablet, 10, blister pack | Is a | Sevikar HCT 40/5/25 tablet, 10 | true | Inferred relationship | Some | ||
| Sevikar HCT 40/5/25 tablet, 10, blister pack | has container type | blister pack | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Description inactivation indicator reference set
Containered trade product pack reference set
FHIR